Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.7M | $19.6M | $19.7M | $20.6M | $17.8M | $17.6M | $19.7M | $21.3M | $28.3M | $28.1M |
| Revenue growth | — | 4.6% | 0.8% | 4.5% | -13.4% | -1.2% | 12.0% | 8.0% | 32.9% | -0.9% |
| Gross profit | $8.79M | $8.66M | $7.49M | $6.92M | $4.47M | $6.73M | $8.38M | $9.34M | $9.19M | $5.06M |
| Gross margin | 47.0% | 44.3% | 38.0% | 33.6% | 25.0% | 38.2% | 42.4% | 43.8% | 32.4% | 18.0% |
| Operating income | $3.29M | $2.41M | $1.86M | $1.54M | -$9.46M | $1.35M | $2.43M | $270K | -$2.81M | -$3.59M |
| Operating margin | 17.6% | 12.3% | 9.4% | 7.5% | -53.1% | 7.7% | 12.3% | 1.3% | -9.9% | -12.8% |
| Net income | $930K | $1.92M | $1.02M | $659K | -$7.06M | $194K | $1.33M | $610K | $2.19M | -$1.55M |
| Net margin | 5.0% | 9.8% | 5.2% | 3.2% | -39.6% | 1.1% | 6.7% | 2.9% | 7.7% | -5.5% |
| EPS (diluted) | $0.17 | $0.33 | $0.17 | $0.11 | -$1.14 | $0.03 | $0.21 | $0.10 | $0.33 | -$0.23 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $8.38M | $7.85M | $8.06M | $8.05M | $9.74M | $6.27M | $7.24M | $5.72M | $167K | $3.10M |
| Capital expenditures | $1.04M | $803K | $1.58M | $990K | $455K | $1.67M | $388K | $6.27M | $7.94M | $7.63M |
| Free cash flow | $7.34M | $7.05M | $6.49M | $7.06M | $9.29M | $4.59M | $6.85M | -$555K | -$7.77M | -$4.54M |
| Share buybacks | $0.00 | — | — | — | — | — | — | — | — | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.87M | $2.15M | $1.44M | $1.43M | $3.96M | $8.14M | $12.3M | $13.7M | $11.0M | $3.46M |
| Total assets | $60.6M | $58.2M | $57.5M | $53.8M | $43.7M | $45.4M | $44.0M | $48.2M | $60.2M | $55.5M |
| Total liabilities | — | — | — | — | — | $21.2M | $18.3M | $21.9M | $30.2M | $27.8M |
| Long-term debt | $5.11M | $3.60M | $3.33M | $1.95M | $3.44M | $14.3M | $12.2M | $11.0M | $17.3M | $0.00 |
| Shareholders' equity | $21.5M | $23.9M | $25.1M | $26.0M | $19.3M | $19.9M | $21.6M | $22.6M | $25.2M | $24.0M |
| Retained earnings | $4.95M | $6.87M | $7.90M | $8.55M | $1.50M | $1.69M | $3.02M | $3.63M | $5.82M | $4.26M |
| Shares (wtd avg diluted) | 5.58M | 5.88M | 5.85M | 5.93M | 6.18M | 6.06M | 6.30M | 6.39M | 6.70M | 6.62M |
Every figure is extracted from AMERICAN SHARED HOSPITAL SERVICES’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.